What is the sensitivity of Non-Invasive Prenatal Testing (NIPT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sensitivity of Non-Invasive Prenatal Testing (NIPT)

Overall Performance for Common Trisomies

NIPT demonstrates exceptionally high sensitivity for detecting fetal chromosomal abnormalities, with 99.3% sensitivity for trisomy 21 (Down syndrome), 97.4% for trisomy 18 (Edwards syndrome), and 97.4% for trisomy 13 (Patau syndrome) in singleton pregnancies. 1

Trisomy 21 (Down Syndrome)

  • Sensitivity: 98.8-99.3% with a false-positive rate of only 0.04% 2, 1
  • This represents a detection rate superior to all traditional screening methods 3
  • Specificity reaches 99.9% across multiple studies 1

Trisomy 18 (Edwards Syndrome)

  • Sensitivity: 97.4-98.83% with a false-positive rate of 0.07% 2, 1
  • In twin pregnancies, sensitivity decreases to 90% (95% CI = 67.6%-97.5%) with specificity of 99.95% 3, 4

Trisomy 13 (Patau Syndrome)

  • Sensitivity: 92.85-97.4% with a false-positive rate of 0.04% 2, 1
  • In twin pregnancies, sensitivity drops to 80% (95% CI = 30.9%-97.3%) with specificity of 99.93% 3, 4

Sex Chromosome Aneuploidies

NIPT shows an overall detection rate of 99.6% (95% CI = 94.8%-100%) for sex chromosome aneuploidies with 99.8% specificity. 3, 2

However, positive predictive values vary significantly by condition:

  • Monosomy X (Turner syndrome): 29.5% PPV (95% CI = 22.7%-37.4%) 3, 2
  • Triple X syndrome (47,XXX): 54% PPV (95% CI = 40.6%-66.8%) 3, 2
  • Klinefelter syndrome (47,XXY): 74% PPV (95% CI = 59.5%-84.7%) 3, 2
  • 47,XYY syndrome: 74.5% PPV (95% CI = 58.4%-85.8%) 3, 2

The lower PPV for monosomy X reflects higher rates of placental mosaicism and maternal mosaicism that would not be detected through amniocentesis 3

Performance in Twin Pregnancies

NIPT maintains excellent performance in twin gestations, with sensitivity of 98.2% for trisomy 21, though slightly reduced for trisomies 18 and 13. 4, 2

  • Trisomy 21: 98.2% sensitivity (95% CI = 88.2%-99.7%) and 99.9% specificity 4
  • Trisomy 18: 90% sensitivity (95% CI = 67.6%-97.5%) and 99.95% specificity 4
  • Trisomy 13: 80% sensitivity (95% CI = 30.9%-97.3%) and 99.93% specificity 4

This represents a 9% reduction in sensitivity for trisomy 21,28% reduction for trisomy 18, and 22% reduction for trisomy 13 compared to singleton pregnancies 1

Critical Factors Affecting Sensitivity

Test Failure and No-Call Results

  • Approximately 1% of samples result in "no-call" results, most commonly due to insufficient fetal fraction 3, 4
  • Repeat testing provides results in 75-80% of cases 3
  • High maternal BMI increases test failure rates up to 20% due to low fetal fraction 4

Timing Considerations

  • NIPT should be performed after 10 weeks gestation when fetal fraction is adequate (10-15% of cell-free DNA is placental origin) 4
  • Sensitivity is lower in first trimester testing compared to later gestational ages 1

Absolute Contraindications

  • Known vanishing twin or triplet: NIPT should NOT be performed due to risk of false-positive results or test failure 4, 5
  • Known maternal malignancy: Relative contraindication due to potential somatic genomic aberrations 4, 2

Comparison to Traditional Screening

NIPT dramatically outperforms traditional screening methods:

  • Traditional second trimester biochemistry: 63% detection rate with 10.8% false-positive rate 3, 4
  • First trimester NT with biochemistry: 75% detection rate with 9% false-positive rate 3, 4
  • NIPT for trisomy 21: 98.8-99.3% detection rate with 0.04% false-positive rate 2

This translates to requiring only 1.1-2 amniocentesis procedures to confirm one case of trisomy 21 with NIPT versus 28-45 procedures with traditional screening 3

Essential Clinical Caveats

  • NIPT is a screening test, not diagnostic - all positive results require confirmatory invasive testing with amniocentesis or chorionic villus sampling 4, 6
  • False-positive results occur in 0.2-1% of cases, and false-negative results are possible 7
  • NIPT cannot replace ultrasound for structural anomaly detection 4
  • Some pregnancies with no-call results have higher rates of fetal chromosome disorders, though this association is not universally confirmed 3

References

Guideline

Medical Necessity Criteria for Noninvasive Prenatal Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Non-Invasive Prenatal Testing in Twin Pregnancies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Prenatal Genetic Testing for Triplets with Spontaneous Reduction to Twins

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Noninvasive prenatal testing.

Obstetrical & gynecological survey, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.